21.09.2015 Views

Advanced Techniques in Diagnostic Microbiology

Advanced Techniques in

Advanced Techniques in

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TABLE 3.2. Application of techniques to detection of specific pathogens.<br />

Pathogen Methods Specimen Sensitivity Specificity Comments<br />

Bacteria<br />

Streptococcus<br />

group A<br />

Streptococcus<br />

pneumoniae<br />

Agglut<strong>in</strong>ation,<br />

rapid EIA,<br />

OIA<br />

Throat swab 70–90+% >95% Often performed at POC. Negatives must be evaluated<br />

by culture.<br />

Rapid EIA Ur<strong>in</strong>e 50–85% 94% Cl<strong>in</strong>ical role still evolv<strong>in</strong>g. Provides adjunct, but not<br />

def<strong>in</strong>itive, diagnostic <strong>in</strong>formation <strong>in</strong> patients at risk<br />

for S. pneumoniae disease.<br />

Legionella spp. IF Respiratory 25–75% 90%+ Requires FA microscope. Cross-reactions with some<br />

other bacteria, especially with polyclonal reagents.<br />

No gold standard for comparison.<br />

EIA or IC Ur<strong>in</strong>e 80–99% 99% Test characteristics well-established only for L.<br />

pneumophilia group 1.<br />

Clostridium difficile Agglut<strong>in</strong>ation, rapid EIA,<br />

ELISA, OIA<br />

Stool 65–100% 88–100% Measured sensitivity and specificity are relative to tissue<br />

culture cytotoxicity. Tests detect<strong>in</strong>g Tox<strong>in</strong> A + B are<br />

more sensitive than those detect<strong>in</strong>g Tox<strong>in</strong> A only.<br />

Helicobacter pylori ELISA Stool 89% 90–94% Used as an alternative to serology and urea breath<br />

test<strong>in</strong>g.<br />

Chlamydia<br />

trachomatis<br />

Men<strong>in</strong>gitis panel (H.<br />

<strong>in</strong>fluenzae, N.<br />

men<strong>in</strong>gitidis, S.<br />

pneumoniae,<br />

group B<br />

Streptococcus)<br />

ELISA Genital 60–70% 97% Be<strong>in</strong>g phased out, but POC versions might be valuable<br />

if sensitivity improves. No s<strong>in</strong>gle-test format<br />

available. Not useful for screen<strong>in</strong>g low-prevalence<br />

populations due to poor specificity.<br />

Agglut<strong>in</strong>ation CSF, ur<strong>in</strong>e Inadequate sensitivity/specificity for rout<strong>in</strong>e cl<strong>in</strong>ical<br />

use. Empirical therapy given for CSF neutrophilia<br />

covers these pathogens, until culture results available.<br />

Positive predictive value of antigen tests is very low<br />

<strong>in</strong> patients without CSF leukocytosis.<br />

32

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!